TG
GILD icon

TLP Group’s Gilead Sciences GILD Stock Holding History

TLP Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,295
Closed -$254K – 178
2018
Q3 		$254K Sell
3,295
-1,014
-24% -$76.6K 0.4% 35
2018
Q2 		$305K Hold
4,309
– – 0.46% 37
2018
Q1 		$325K Sell
4,309
-348
-7% -$27.7K 0.22% 92
2017
Q4 		$334K Buy
4,657
+348
+8% +$26.4K 0.23% 54
2017
Q3 		$349K Buy
+4,309
New +$329K 0.22% 32
2017
Q2 		– Sell
-5,600
Closed -$380K – 362
2017
Q1 		$380K Buy
+5,600
New +$394K 0.26% 93
2016
Q1 		– Sell
-3,078
Closed -$311K – 330
2015
Q4 		$311K Buy
+3,078
New +$320K 0.25% 75

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TLP Group's GILD Position: Q4 2018 in Review

TLP Group sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,295 shares — an estimated $254K sold.

TLP Group first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $380K in Q1 2017. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • TLP Group reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • TLP Group sold 3,295 Gilead Sciences shares in Q4 2018, an estimated $254K.
  • TLP Group first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • TLP Group's Gilead Sciences position peaked at $380K in Q1 2017.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.